This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q33496113

rdf:type

wikibase:Item

schema:description

artigo científico 1996年论文 bilimsel makale επιστημονικό άρθρο 1996年论文 научная статья articol științific wissenschaftlicher Artikel מאמר מדעי ১৯৯৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk artikulong pang-agham vědecký článek 1996년 논문 scienca artikolo 1996年論文 1996 nî lūn-bûn bài báo khoa học 1996年论文 scientific article published in July 1996 naučni članak სამეცნიერო სტატია научни чланак 1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած scientific article published in July 1996 1996 թվականի հուլիսին հրատարակված գիտական հոդված мақолаи илмӣ مقالة علمية نشرت في يوليو 1996 wetenschappelijk artikel tieteellinen artikkeli 1996年の論文 1996年論文 vitenskapelig artikkel vedecký článok บทความทางวิทยาศาสตร์ article científic scientific article published in July 1996 vetenskaplig artikel article scientific articolo scientifico 1996年論文 teaduslik artikkel 1996年论文 artículu científicu espublizáu en 1996 artigo científico 1996年论文 artículo científico publicado en 1996 artykuł naukowy videnskabelig artikel 1996年論文 научна статия artigo científico научни чланак vitskapeleg artikkel article scientifique наукова стаття, опублікована в липні 1996 мақолаи илмӣ mokslinis straipsnis 1996年論文 artikull shkencor 1996年论文 artikel ilmiah

p:P577

wds:Q33496113-F571A8CC-685D-4AFE-A532-E21DD5C46902

wdt:P577

1996-07-01T00:00:00Z

p:P407

wds:Q33496113-698049E5-1148-4069-B804-B8D76B75507D

wdt:P407

wd:Q1860

p:P2093

wds:Q33496113-10DDE145-EED4-4213-A182-A7D5CD5880C7 wds:Q33496113-0B4D9840-4206-45D4-903F-E64F55D18013 wds:Q33496113-3B023690-6848-44B0-8C53-EF968410C9EA wds:Q33496113-40CC4FE8-7AFB-483B-B490-38F754D1D946 wds:Q33496113-607F91F2-87DE-4723-A66E-EB3B40B7D3F7 wds:Q33496113-B2222E24-273E-46F0-8B29-FDBFECEA6ACA wds:Q33496113-B94537B1-67D3-47D8-9B90-6340189CAD2B wds:Q33496113-998ECB2D-3D14-4DD9-8E31-8FE4D01EC593 wds:Q33496113-FBD23593-A4AA-4E72-B517-F28433DB5E43 wds:Q33496113-B957A651-82B5-44A7-BEED-25ED3F2524E7

wdt:P2093

C Terret S Kaul D Abigerges L Igwemezie M Bonnay M de Forni G G Chabot J P Armand B Winograd L Schacter

rdfs:label

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

skos:prefLabel

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

schema:name

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

p:P50

wds:Q33496113-4A893512-94E6-4636-973E-AA0B9EC64D04

wdt:P50

wd:Q48084039

p:P1476

wds:Q33496113-2EE2AC72-15A9-46DC-804B-92917C5AB32A

wdt:P1476

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

p:P304

wds:Q33496113-777CD684-F5A0-40FF-9F9D-B19934B44DDB

wdt:P304

2020-2030

p:P31

wds:Q33496113-78B8FD08-38B0-4B00-8E2C-B70268388FB5

wdt:P31

wd:Q13442814

p:P921

wds:Q33496113-5367E6E4-A0F6-4603-97FF-58F250EBF1B5 wds:Q33496113-80E256B5-D0B1-4262-8FF2-4B378BF38FF4

wdt:P921

wd:Q461809 wd:Q418817

p:P698

wds:Q33496113-088BE249-713F-4BE6-A253-53C03A599A28

wdtn:P698

n11:8683232

wdt:P698

8683232

p:P1433

wds:Q33496113-2A4A2D27-E918-44B3-9A8F-1017CE2418FD

wdt:P1433

wd:Q400292

p:P433

wds:Q33496113-3C4C60B3-F2CE-4C23-AFD6-29FF57F1F413

p:P478

wds:Q33496113-1F4675E7-7188-4188-81DE-09275059DA9B

wdt:P433

7

wdt:P478

14

p:P356

wds:Q33496113-4D272482-1B0C-41F8-A150-5621A9B16C87

wdtn:P356

n12:JCO.1996.14.7.2020

wdt:P356

10.1200/JCO.1996.14.7.2020